** Ansell shares ANN.AX drop 0.7% to A$25.45
** Macquarie expects medical supplies provider's FY24 EPS
will be US$0.97 vs Co forecast of US$0.94-$1.10
** Brokerage keeps 'outperform' rating; A$28.15 price target
** Still, says EPS outlook is favourable on expectations
de-stocking in life sciences unit will normalise and on
Kimberly-Clark KMB.N transaction
** Avg rating of 11 analysts is "hold"; median PT is A$26.62
- LSEG data
** ANN is up just over 1% YTD, after a four-year losing
streak
(Reporting by Shivangi Lahiri in Bengaluru)
((shivangi.lahiri@thomsonreuters.com))